Article - Better Understanding of Ovarian Cancer I
Post# of 72444

"Studies are already underway in this area, and have revealed some intriguing results. As approximately 96 percent of patients with high-grade serous ovarian cancer harbor the tumor suppressor p53 gene, WEE1 inhibitors have demonstrated evidence of chemopotentiation in p53-deficient tumors."
http://www.curetoday.com/articles/better-unde...xpert-says


Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
